DM0000: The mark consists of the wording, "EXSCIENTIA" over the wording, "DRIVEN BY KNOWLEDGE.
GS0091: Downloadable computer software for analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics; Downloadable computer software for computer assisted molecule design; Downloadable computer software for chemical and biological research and analysis; Downloadable computer software for pharmaceutical research and development services; Downloadable computer software for diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes for use in the field of molecular research and to combat disease; downloadable computer software for use in the research and development of pharmaceutical products; downloadable computer software for cell analysis; downloadable computer software for the use in managing scientific projects; downloadable computer software for the design of chemical structures; downloadable computer software for the analysis of biological or chemical activity; downloadable artificial intelligence software for healthcare, pharmaceuticals and diagnostics
GS0051: Pharmaceutical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Medical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Veterinary preparations for the treatment of pain, viral diseases, namely, paramyxovirus, influenza A virus, coronavirus, herpes, and hepatitis, wounds, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, mental health disorders, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, cardiovascular diseases and disorders, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, arthritis, inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases, immunologic diseases and disorders, namely Alzheimer's, ulcerative colitis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), allergies, and anxiety; veterinary preparations, namely, vaccines for animals, and sanitary substances for medical use for the treatment of autoimmune diseases, autoimmune diseases, specifically psoriasis, arthritis, and Crohn's disease; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use, food for babies; dietetic substances in the nature of dietetic food adapted for medical or veterinary use; Dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze, bandages; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical, veterinary and sanitary substances and preparations, namely, antifungals, antivirals, herbicides, antibiotics
TR0010: The English translation of "EXSCIENTIA" in the mark is "FROM KNOWLEDGE".
GS0441: Medical diagnostic testing and medical screening services
GS0421: Scientific and technological services, namely, scientific research, analysis, testing in the field of research and development of pharmaceutical products and molecule design and services relating thereto; industrial analysis and industrial research services in the field of research and development of pharmaceutical products, molecule design and robotics for lab automation and industrial design services; quality control and authentication services in the field of works of scientific research for others; design and development of computer hardware and software; Bioinformatic services, namely, analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics for others; computer assisted molecule design; identification of biological targets, networks and pathways; chemical and biological research and analysis; pharmaceutical research and development services; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes to combat diseases
Case File Event Statements
5/19/2022 - 2 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
5/20/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
5/24/2022 - 2 years ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
11/4/2022 - 2 years ago
4 - CHANGE OF NAME/ADDRESS REC'D FROM IBType:ADCH
12/27/2022 - 2 years ago
7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
12/25/2022 - 2 years ago
5 - ASSIGNED TO EXAMINERType:DOCK
12/26/2022 - 2 years ago
6 - NON-FINAL ACTION WRITTENType:CNRT
2/22/2023 - a year ago
8 - REFUSAL PROCESSED BY MPUType:RFRR
2/22/2023 - a year ago
9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
3/15/2023 - a year ago
10 - REFUSAL PROCESSED BY IBType:RFNT
8/21/2023 - a year ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
8/21/2023 - a year ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
8/21/2023 - a year ago
13 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
9/16/2023 - a year ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
10/4/2023 - a year ago
17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
10/4/2023 - a year ago
15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
10/4/2023 - a year ago
16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
10/24/2023 - a year ago
18 - PUBLISHED FOR OPPOSITIONType:PUBO
10/24/2023 - a year ago
19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
10/24/2023 - a year ago
20 - NOTIFICATION PROCESSED BY IBType:GPNX
10/25/2023 - a year ago
21 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IBType:OPNR
10/25/2023 - a year ago
22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
11/12/2023 - a year ago
23 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IBType:OPNX
1/9/2024 - a year ago
25 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
1/9/2024 - a year ago
24 - REGISTERED-PRINCIPAL REGISTERType:R.PR
4/10/2024 - 10 months ago
28 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
4/10/2024 - 10 months ago
27 - FINAL DISPOSITION PROCESSEDType:FIMP
4/29/2024 - 9 months ago
29 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
6/1/2024 - 8 months ago
30 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
4/9/2024 - 10 months ago
26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
Trademark
79340816
